175 related articles for article (PubMed ID: 24484542)
1. High response rate but short-term effect of romiplostim in paediatric refractory chronic immune thrombocytopenia.
Seidel MG; Urban C; Sipurzynski J; Beham-Schmid C; Lackner H; Benesch M
Br J Haematol; 2014 May; 165(3):419-21. PubMed ID: 24484542
[No Abstract] [Full Text] [Related]
2. Treatment of chronic immune thrombocytopenia in children with romiplostim.
Chaturvedi S; McCrae KR
Lancet; 2016 Jul; 388(10039):4-6. PubMed ID: 27103125
[No Abstract] [Full Text] [Related]
3. Response of refractory immune thrombocytopenia after bone marrow transplantation to romiplostim.
Beck JC; Burke MJ; Tolar J
Pediatr Blood Cancer; 2010 Mar; 54(3):490-1. PubMed ID: 19908296
[No Abstract] [Full Text] [Related]
4. Remissions after long-term use of romiplostim for immune thrombocytopenia.
Marshall AL; Scarpone R; De Greef M; Bird R; Kuter DJ
Haematologica; 2016 Dec; 101(12):e476-e478. PubMed ID: 27587382
[No Abstract] [Full Text] [Related]
5. Pseudothrombocytopenia in a patient receiving romiplostim for immune thrombocytopenic purpura.
Fozza C; Pardini S; Marras T; Longu F; Isoni A; Contini S; Longinotti M
Ann Hematol; 2014 May; 93(5):899-900. PubMed ID: 24081576
[No Abstract] [Full Text] [Related]
6. Successful treatment of Immune Thrombocytopenic Purpura (ITP) with the thrombopoietin-mimetic romiplostim.
Meletis J; Katsandris A; Raptis SD; Mantzourani M
Med Sci Monit; 2010 Aug; 16(8):CS100-2. PubMed ID: 20671616
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of romiplostim in patients with eltrombopag-resistant or -intolerant immune thrombocytopenia.
Tsukamoto S; Nakaseko C; Takeuchi M; Kumagai K; Komatsu T; Tanaka H; Hara S; Koizumi M; Imai H; Yokota A; Takeuchi M; Inokuchi K; Matsuura Y; Aotsuka N; Wakita H
Br J Haematol; 2013 Oct; 163(2):286-9. PubMed ID: 23862773
[No Abstract] [Full Text] [Related]
8. Successful treatment of eltrombopag-resistant refractory immune thrombocytopenia with romiplostim.
Nakazato T; Ito C; Mihara A; Aisa Y
Int J Hematol; 2013 Feb; 97(2):291-3. PubMed ID: 23275229
[No Abstract] [Full Text] [Related]
9. Comment on: Use of thrombopoietin receptor agonist (romiplostim) in neonatal autoimmune thrombocytopenia due to maternal immune thrombocytopenia.
Mahat U; Talati R; Kodish E
Pediatr Blood Cancer; 2019 Jun; 66(6):e27706. PubMed ID: 30854752
[No Abstract] [Full Text] [Related]
10. New synergistic efficacy of combination of romiplostim and steroid in refractory immune thrombocytopenia patients.
Yoon JS; Lee YJ; Baek DW; Park HY; Park BE; Moon JH; Sohn SK
Korean J Intern Med; 2018 Mar; 33(2):435-437. PubMed ID: 26947025
[No Abstract] [Full Text] [Related]
11. Romiplostim for the treatment of glioblastoma-related paraneoplastic autoimmune thrombocytopenia refractory to conventional therapy.
Rodríguez-Lobato LG; Martinez-Cibrian N; Fernández-Avilés F; Gaya A; Pineda-Losada E; Esteve J
Ann Hematol; 2016 Mar; 95(4):665-6. PubMed ID: 26787417
[No Abstract] [Full Text] [Related]
12. Restored platelet function after romiplostim treatment in a patient with immune thrombocytopenic purpura.
Gardiner EE; Thom JY; Al-Tamimi M; Hughes A; Berndt MC; Andrews RK; Baker RI
Br J Haematol; 2010 May; 149(4):625-8. PubMed ID: 20148887
[No Abstract] [Full Text] [Related]
13. Romiplostim for management of refractory immune thrombocytopenic purpura in the immediate postpartum period.
Patras A; Figueroa R; Singh AP; Madan I
BMJ Case Rep; 2020 May; 13(5):. PubMed ID: 32430352
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of concomitant treatment with romiplostim and warfarin in a patient with immune thrombocytopenia and severe cardiac comorbidities.
Baldini S; Rigacci L; Carrai V; Fjerza R; Alterini R; Bosi A
Platelets; 2013; 24(3):242-3. PubMed ID: 22646237
[No Abstract] [Full Text] [Related]
15. Romiplostim in chronic immune thrombocytopenic purpura.
Cersosimo RJ
Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
[TBL] [Abstract][Full Text] [Related]
16. Romiplostim in children with chronic immune thrombocytopenia (ITP): the French experience.
Pasquet M; Aladjidi N; Guiton C; Courcoux MF; Munzer M; Auvrignon A; Lutz P; Ducassou S; Leroy G; Munzer C; Leverger G;
Br J Haematol; 2014 Jan; 164(2):266-71. PubMed ID: 24152194
[TBL] [Abstract][Full Text] [Related]
17. [Successful switching from eltrombopag to romiplostim in a pediatric patient with refractory chronic ITP].
Mori M; Kato M; Koh K; Hanada R
Rinsho Ketsueki; 2015 May; 56(5):511-3. PubMed ID: 26062675
[TBL] [Abstract][Full Text] [Related]
18. Use of a thrombopoietin mimetic for chronic immune thrombocytopenic purpura in pregnancy.
Patil AS; Dotters-Katz SK; Metjian AD; James AH; Swamy GK
Obstet Gynecol; 2013 Aug; 122(2 Pt 2):483-485. PubMed ID: 23884268
[TBL] [Abstract][Full Text] [Related]
19. Romiplostim as an early treatment for refractory immune thrombocytopenia in a 2-month-old infant.
Chiba Y; Tasaka K; Matsubara K; Mori M; Muraoka M; Hamabata T; Nodomi S; Waki K
Pediatr Blood Cancer; 2024 Jun; 71(6):e30953. PubMed ID: 38520052
[No Abstract] [Full Text] [Related]
20. Rescue therapy with romiplostim for refractory primary immune thrombocytopenia during pregnancy.
Decroocq J; Marcellin L; Le Ray C; Willems L
Obstet Gynecol; 2014 Aug; 124(2 Pt 2 Suppl 1):481-483. PubMed ID: 25004319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
